title: Cyclosporine reversibly inhibits natural killer-cell activity.
authors.affiliation: Department of Surgery, Catholic University of Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Citterio
authors.forename: R
authors.initials: R
authors.lastname: Cauda
authors.forename: M
authors.initials: M
authors.lastname: Tumbarello
authors.forename: U
authors.initials: U
authors.lastname: Pozzetto
authors.forename: L
authors.initials: L
authors.lastname: Ortona
authors.forename: M
authors.initials: M
authors.lastname: Castagneto
mesh_terms: D003524:Cyclosporins / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007113:Immunity, Innate / Q000187:drug effects; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects; D007694:Killer Cells, Natural / Q000187:drug effects*; D011994:Recombinant Proteins
chemical_list: D003524:Cyclosporins; D007376:Interleukin-2; D011994:Recombinant Proteins